Holtz W, Schmidt-Baulain R, Welp C, Wallenhorst C K
Institute of Animal Husbandry and Genetics, University of Goettingen, Germany.
Anim Reprod Sci. 1999 Dec 15;57(3-4):177-83. doi: 10.1016/s0378-4320(99)00054-8.
Prepuberal gilts reared and managed to 85-90 kg live weight in a common system were allocated at random to one of three first-mating treatments in an experiment conducted over a period of more than 5 years. In two of the treatments, gilts received a single i.m. injection of 400 IU equine chorionic gonadotropin (eCG) and 200 IU human chorionic gonadotropin (hCG) (PG600; Intervet) and were either inseminated 4 and 5 days later on a fixed-time basis regardless of oestrus (treatment A), or at the second oestrus following treatment (treatment B). The third group of gilts remained untreated and was inseminated on the first spontaneous oestrus (treatment C). Thereafter, all gilts were managed in the same way and those observed in oestrus were re-inseminated. Significantly more gilts returned to oestrus after the first service in treatment A (35%) than in treatment B and C (12 and 17%, respectively; P<0.01). Gilts farrowed to the first or repeat inseminations at a significantly younger age (P<0.01) in treatment A (304 days) than treatment B (324 days) and C (320 days). The age difference at farrowing remained in surviving gilts at the end of their third parity. The first farrowing performance of the gilts was significantly affected by treatment in terms of litter size at birth (A 7.0, B 8.4 and C 8.3 live piglets per gilt; P<0.01), litter size at weaning (A 6.2, B 7.2 and C 7.2 live piglets per gilt, P<0.05), and piglet birth weight (A 1.4, B 1.3 and C 1.3 kg; P<0.05) but piglet survival rate and weaning weight were not affected by treatment. The live weights of the gilts were significantly different between the treatments at first insemination (A 95.7, B 106.5 and C 109.2 kg; P<0.01) but not when the first litter was weaned (A 133.6, B 135.1 and C 136.6; P>0.05). After the first farrowing there were no differences between the treatments in terms of the survival rate, productive or reproductive performance of the gilts/sows and their offspring. Without conducting a detailed cost-benefit-calculation it was deduced that, from an economical point of view, differences between treatment A and treatments B and C are negligible because the savings associated with farrowing at a younger age on this treatment just about compensated for any additional costs associated with the treatment and the lower number of piglets born at the first farrowing.
在一个持续超过5年的实验中,将按照常规饲养管理至85 - 90公斤活重的青春期前小母猪随机分配到三种首次配种处理方式中的一种。在两种处理方式中,小母猪接受一次肌肉注射400国际单位马绒毛膜促性腺激素(eCG)和200国际单位人绒毛膜促性腺激素(hCG)(PG600;英特威),并且要么在注射后第4天和第5天进行定时输精,不考虑发情情况(处理A),要么在处理后的第二次发情时输精(处理B)。第三组小母猪不进行处理,在首次自然发情时输精(处理C)。此后,所有小母猪以相同方式管理,观察到发情的小母猪进行再次输精。处理A中首次输精后返情的小母猪(35%)显著多于处理B和C(分别为12%和17%;P<0.01)。处理A中小母猪首次或重复输精后产仔时的年龄显著更小(P<0.01)(304天),而处理B为324天,处理C为320天。在第三胎产仔结束时,存活小母猪的产仔年龄差异依然存在。小母猪的首次产仔性能在出生窝仔数(处理A每头小母猪7.0头、处理B 8.4头、处理C 8.3头活仔猪;P<0.01)、断奶窝仔数(处理A每头小母猪6.2头、处理B 7.2头、处理C 7.2头活仔猪,P<0.05)以及仔猪出生体重(处理A 1.4公斤、处理B 1.3公斤、处理C 1.3公斤;P<0.05)方面受到处理的显著影响,但仔猪存活率和断奶体重不受处理影响。首次输精时小母猪的活重处理间存在显著差异(处理A 95.7公斤、处理B 106.5公斤、处理C 109.2公斤;P<0.01),但第一窝仔猪断奶时无差异(处理A 133.6公斤、处理B 135.1公斤、处理C 136.6公斤;P>0.05)。首次产仔后,在小母猪/母猪及其后代的存活率、生产性能或繁殖性能方面,各处理间无差异。在未进行详细成本效益计算的情况下推断,从经济角度看,处理A与处理B和C之间的差异可忽略不计,因为该处理方式下因产仔年龄较小带来的节省几乎抵消了与该处理相关的任何额外成本以及首次产仔时出生仔猪数量较少的影响。